MIPHARM SPA
Egidio D'Amelia is an experienced quality systems professional currently serving as the Quality Systems Head at Mipharm S.p.A. since December 2016, overseeing change control, supplier management, product quality reviews, audits, CAPA, training, and the machinability of materials. Prior to this role, Egidio worked as a QA Pharmaceutical Packaging Engineering Supervisor at Mipharm, focusing on the sampling and approval of packaging materials. Additionally, Egidio served as a Pharmaceutical Validation Specialist at Ingegneria Biomedica Santa Lucia and completed a Quality Assurance internship at Bayer - Intendis Manufacturing S.p.A. Egidio holds a Laurea specialistica in Chemistry and Pharmaceutical Technology from the Università degli Studi di Pavia and a scientific diploma from Liceo Scientifico Benedetto Cairoli.
This person is not in any teams
MIPHARM SPA
Mipharm S.p.A. was born in January 1998 following the merger of Sandoz and Ciba Geigy, from which resulted the new company Novartis. Mipharm was founded by a group of ex managers coming from Novartis by mean of a spin-off of the manufacturing site located in Milan, Via Quaranta, previously owned by Sandoz. In December 2016, Mandarin Capital Partners II acquired the majority stake in Mipharm share capital. Today, Mipharm is one of the most valuable third party manufacturing and new product development sites in Italy and it claims to have four FDA approvals (Nasal Spray Solution, Oral Potent Drug, Sachet, Packaging). Mipharm has been investing significant resources to continuously improve manufacturing site qualitative standard and currently it is able to produce and to pack a huge range of products and pharmaceutical forms.